Hoya Corp (HOCPY)
116.84
-0.65
(-0.55%)
USD |
OTCM |
Apr 26, 15:59
Hoya Price to Book Value: 6.557 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 6.593 |
| April 24, 2024 | 6.694 |
| April 23, 2024 | 6.434 |
| April 22, 2024 | 6.401 |
| April 19, 2024 | 6.260 |
| April 18, 2024 | 6.379 |
| April 17, 2024 | 6.362 |
| April 16, 2024 | 6.332 |
| April 15, 2024 | 6.188 |
| April 12, 2024 | 6.103 |
| April 11, 2024 | 6.245 |
| April 10, 2024 | 6.227 |
| April 09, 2024 | 6.447 |
| April 08, 2024 | 6.483 |
| April 05, 2024 | 6.498 |
| April 04, 2024 | 6.734 |
| April 03, 2024 | 6.802 |
| April 02, 2024 | 6.863 |
| April 01, 2024 | 6.976 |
| March 28, 2024 | 6.989 |
| March 27, 2024 | 7.021 |
| March 26, 2024 | 7.111 |
| March 25, 2024 | 7.076 |
| March 22, 2024 | 7.284 |
| March 21, 2024 | 7.411 |
| Date | Value |
|---|---|
| March 20, 2024 | 7.377 |
| March 19, 2024 | 7.263 |
| March 18, 2024 | 7.295 |
| March 15, 2024 | 7.218 |
| March 14, 2024 | 7.081 |
| March 13, 2024 | 7.149 |
| March 12, 2024 | 7.255 |
| March 11, 2024 | 7.256 |
| March 08, 2024 | 7.435 |
| March 07, 2024 | 7.506 |
| March 06, 2024 | 7.433 |
| March 05, 2024 | 7.350 |
| March 04, 2024 | 7.360 |
| March 01, 2024 | 7.518 |
| February 29, 2024 | 7.302 |
| February 28, 2024 | 7.066 |
| February 27, 2024 | 7.136 |
| February 26, 2024 | 7.266 |
| February 23, 2024 | 7.107 |
| February 22, 2024 | 7.116 |
| February 21, 2024 | 6.890 |
| February 20, 2024 | 6.905 |
| February 16, 2024 | 6.974 |
| February 15, 2024 | 6.958 |
| February 14, 2024 | 6.855 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.592
Minimum
Jun 03 2019
10.05
Maximum
Sep 14 2021
6.500
Average
6.278
Median
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.8556 |
| Nxera Pharma Co Ltd | 1.756 |
| PeptiDream Inc | 4.303 |
| Stemcell Holdings Inc | -- |
| Healios KK | 3.273 |
Price to Book Value Related Metrics
| PE Ratio | 34.68 |
| PS Ratio | 7.455 |
| Price to Free Cash Flow | 33.98 |
| Price | 116.84 |
| Earnings Yield | 2.88% |
| Market Cap | 40.95B |
| Operating PE Ratio | 13.67 |
| Normalized PE Ratio | 33.25 |